HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Prenatal exome sequencing analysis in fetal structural anomalies detected by ultrasonography (PAGE): a cohort study.
|
30712880 |
2019 |
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
The prevalence of CHD7 missense versus truncating mutations is higher in patients with Kallmann syndrome than in typical CHARGE patients.
|
25077900 |
2014 |
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
Mutations in FGF17, IL17RD, DUSP6, SPRY4, and FLRT3 are identified in individuals with congenital hypogonadotropic hypogonadism.
|
23643382 |
2013 |
Kallmann Syndrome
|
0.600 |
GermlineCausalMutation
|
disease |
ORPHANET |
In addition, we show that PROKR2 haploinsufficiency is not sufficient to cause Kallmann syndrome or normosmic HH, whereas homozygous loss-of-function mutations either in PROKR2 or PROK2 are sufficient to cause disease phenotype, in accordance with the Prokr2 and Prok2 knockout mouse models.
|
18682503 |
2008 |
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Mutations in prokineticin 2 and prokineticin receptor 2 genes in human gonadotrophin-releasing hormone deficiency: molecular genetics and clinical spectrum.
|
18559922 |
2008 |
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
Mutations in prokineticin 2 and prokineticin receptor 2 genes in human gonadotrophin-releasing hormone deficiency: molecular genetics and clinical spectrum.
|
18559922 |
2008 |
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
Kallmann syndrome: mutations in the genes encoding prokineticin-2 and prokineticin receptor-2.
|
17054399 |
2006 |
Kallmann Syndrome
|
0.600 |
Biomarker
|
disease |
CTD_human |
|
|
|
Major Depressive Disorder
|
0.320 |
Biomarker
|
disease |
PSYGENET |
Based on LPS-stimulated blood gene expression using whole-genome microarrays (primary cohort; 21 MDD patients, 21 healthy control subjects), we identified a set of genes (CAPRIN1, CLEC4A, KRT23, MLC1, PLSCR1, PROK2, ZBTB16) that serves as a molecular signature of MDD.
|
20471630 |
2010 |
Mood Disorders
|
0.320 |
Biomarker
|
group |
PSYGENET |
To evaluate the association between PROK2, PROKR2, and mood disorders, we conducted a case-control study of Japanese samples (151 bipolar patients, 319 major depressive disorder patients, and 340 controls) with four and five tagging SNPs in PROK2 or PROKR2, respectively, selected by HapMap database.
|
19544013 |
2009 |
Major Depressive Disorder
|
0.320 |
Biomarker
|
disease |
PSYGENET |
To evaluate the association between PROK2, PROKR2, and mood disorders, we conducted a case-control study of Japanese samples (151 bipolar patients, 319 major depressive disorder patients, and 340 controls) with four and five tagging SNPs in PROK2 or PROKR2, respectively, selected by HapMap database.
|
19544013 |
2009 |
Unipolar Depression
|
0.310 |
Biomarker
|
disease |
PSYGENET |
Stimulated gene expression profiles as a blood marker of major depressive disorder.
|
20471630 |
2010 |
Unipolar Depression
|
0.310 |
Biomarker
|
disease |
PSYGENET |
To evaluate the association between PROK2, PROKR2, and mood disorders, we conducted a case-control study of Japanese samples (151 bipolar patients, 319 major depressive disorder patients, and 340 controls) with four and five tagging SNPs in PROK2 or PROKR2, respectively, selected by HapMap database.
|
19544013 |
2009 |
Hyperalgesia
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Impaired nociception and inflammatory pain sensation in mice lacking the prokineticin receptor PKR1: focus on interaction between PKR1 and the capsaicin receptor TRPV1 in pain behavior.
|
16793879 |
2006 |
Allodynia
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Impaired nociception and inflammatory pain sensation in mice lacking the prokineticin receptor PKR1: focus on interaction between PKR1 and the capsaicin receptor TRPV1 in pain behavior.
|
16793879 |
2006 |
Hyperalgesia, Primary
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Impaired nociception and inflammatory pain sensation in mice lacking the prokineticin receptor PKR1: focus on interaction between PKR1 and the capsaicin receptor TRPV1 in pain behavior.
|
16793879 |
2006 |
Hyperalgesia, Secondary
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Impaired nociception and inflammatory pain sensation in mice lacking the prokineticin receptor PKR1: focus on interaction between PKR1 and the capsaicin receptor TRPV1 in pain behavior.
|
16793879 |
2006 |
Tactile Allodynia
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Impaired nociception and inflammatory pain sensation in mice lacking the prokineticin receptor PKR1: focus on interaction between PKR1 and the capsaicin receptor TRPV1 in pain behavior.
|
16793879 |
2006 |
Hyperalgesia, Thermal
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Impaired nociception and inflammatory pain sensation in mice lacking the prokineticin receptor PKR1: focus on interaction between PKR1 and the capsaicin receptor TRPV1 in pain behavior.
|
16793879 |
2006 |
Mechanical Allodynia
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Impaired nociception and inflammatory pain sensation in mice lacking the prokineticin receptor PKR1: focus on interaction between PKR1 and the capsaicin receptor TRPV1 in pain behavior.
|
16793879 |
2006 |
Kallmann Syndrome 1
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Kallmann Syndrome 2 (disorder)
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Kallmann syndrome, type 3, recessive
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|